Human antibodies generated in vitro may be highly valuable for diagnostic and therapeutic purposes. For a long time most human antibodies produced in vitro have been of the IgM isotype with rather low affinities. In this thesis a method for production of IgG switched antigen-specific human antibodies is presented. This is a two step protocol, in which the first step is a selection procedure of donors with sufficient T-cell reactivity against tetanus toxoid (TT). The culture consists of a primary and a secondary immunization, of peripheral blood cells, where the secondary step includes CD40 activation together with antigen and preactivated T cells. The antigen is a heterotope with one B- and one T-cell (TT) epitope. In the model system 60 % ...
Finding new methods for generating human monoclonal antibodies is an active research field that is i...
Finding new methods for generating human monoclonal antibodies is an active research field that is i...
The development of technologies to generate cell lines producing monoclonal antibodies of human orig...
In vitro antibody responses to a synthetic immunogen, consisting of both a B cell [V3 loop of gp120 ...
We need to understand the major signalling events in human B cell differentiation in order to be abl...
Polyclonal preparations of therapeutic immunoglobulins, namely intravenous immunoglobulins (IVIg), a...
The mechanisms governing the induction of IgG subclasses by T-helper cells in humans were investigat...
Passive transfer of antibodies not only provides immediate short-term protection against disease, bu...
Passive transfer of antibodies not only provides immediate short-term protection against disease, bu...
Passive transfer of antibodies not only provides immediate short-term protection against disease, bu...
BACKGROUND: Passive transfer of antibodies not only provides immediate short-term protection against...
To investigate cellular interactions between human T and B lymphocytes in various diseases, we estab...
Finding new methods for generating human monoclonal antibodies is an active research field that is i...
BACKGROUND: Passive transfer of antibodies not only provides immediate short-term protection against...
Finding new methods for generating human monoclonal antibodies is an active research field that is i...
Finding new methods for generating human monoclonal antibodies is an active research field that is i...
Finding new methods for generating human monoclonal antibodies is an active research field that is i...
The development of technologies to generate cell lines producing monoclonal antibodies of human orig...
In vitro antibody responses to a synthetic immunogen, consisting of both a B cell [V3 loop of gp120 ...
We need to understand the major signalling events in human B cell differentiation in order to be abl...
Polyclonal preparations of therapeutic immunoglobulins, namely intravenous immunoglobulins (IVIg), a...
The mechanisms governing the induction of IgG subclasses by T-helper cells in humans were investigat...
Passive transfer of antibodies not only provides immediate short-term protection against disease, bu...
Passive transfer of antibodies not only provides immediate short-term protection against disease, bu...
Passive transfer of antibodies not only provides immediate short-term protection against disease, bu...
BACKGROUND: Passive transfer of antibodies not only provides immediate short-term protection against...
To investigate cellular interactions between human T and B lymphocytes in various diseases, we estab...
Finding new methods for generating human monoclonal antibodies is an active research field that is i...
BACKGROUND: Passive transfer of antibodies not only provides immediate short-term protection against...
Finding new methods for generating human monoclonal antibodies is an active research field that is i...
Finding new methods for generating human monoclonal antibodies is an active research field that is i...
Finding new methods for generating human monoclonal antibodies is an active research field that is i...
The development of technologies to generate cell lines producing monoclonal antibodies of human orig...